Singapore markets open in 3 hours 24 minutes
Straits Times Index
3,348.87 +12.28 (+0.37%) S&P 500
5,283.40 +5.89 (+0.11%) Dow
38,571.03 -115.29 (-0.30%) Nasdaq
16,828.67 +93.65 (+0.56%) Bitcoin USD
68,995.19 +1,203.52 (+1.78%) CMC Crypto 200
1,450.10 -17.83 (-1.21%)
Arcutis Biotherapeutics, Inc. (ARQT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 967.79M |
| Enterprise value | 770.66M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 6.43 |
| Price/book (mrq) | 4.30 |
| Enterprise value/revenue | 7.24 |
| Enterprise value/EBITDA | -2.04 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.18 |
| 52-week change 3 | -2.34% |
| S&P500 52-week change 3 | 23.49% |
| 52-week high 3 | 13.17 |
| 52-week low 3 | 1.76 |
| 50-day moving average 3 | 9.36 |
| 200-day moving average 3 | 6.34 |
Share statistics
| Avg vol (3-month) 3 | 3.35M |
| Avg vol (10-day) 3 | 2.88M |
| Shares outstanding 5 | 115.76M |
| Implied shares outstanding 6 | 115.76M |
| Float 8 | 89.29M |
| % held by insiders 1 | 2.16% |
| % held by institutions 1 | 109.17% |
| Shares short (15 May 2024) 4 | 22.17M |
| Short ratio (15 May 2024) 4 | 7.45 |
| Short % of float (15 May 2024) 4 | 23.76% |
| Short % of shares outstanding (15 May 2024) 4 | 19.15% |
| Shares short (prior month 15 Apr 2024) 4 | 19.66M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -204.36% |
| Operating margin (ttm) | -63.79% |
Management effectiveness
| Return on assets (ttm) | -28.62% |
| Return on equity (ttm) | -119.24% |
Income statement
| Revenue (ttm) | 106.39M |
| Revenue per share (ttm) | 1.30 |
| Quarterly revenue growth (yoy) | 1,682.40% |
| Gross profit (ttm) | N/A |
| EBITDA | -194.94M |
| Net income avi to common (ttm) | -217.42M |
| Diluted EPS (ttm) | -2.79 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 403.87M |
| Total cash per share (mrq) | 3.49 |
| Total debt (mrq) | 206.74M |
| Total debt/equity (mrq) | 91.91% |
| Current ratio (mrq) | 9.89 |
| Book value per share (mrq) | 1.95 |
Cash flow statement
| Operating cash flow (ttm) | -198.32M |
| Levered free cash flow (ttm) | -119.82M |
© 2024 Yahoo. All rights reserved.